NCT00896896|Completed
Loading search results
Sponsor study identifier
Secondary identifiers
observational
538
0 countries
N/A
Study Start
November 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)RATIONALE: Studying samples of blood in the laboratory may help doctors predict which patients will develop hypersensitivity to cetuximab. PURPOSE: This research study is looking at hypersensitivity to cetuximab in patients with head and neck cancer or advanced colorectal cancer previously treated with cetuximab.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2006
Date type not reportedThis date has not been verified as actual or estimated.
October 2008
Actual (reported)October 2008
Actual (reported)May 9, 2009
Actual (reported)May 12, 2009
Actual (reported)Identification of antibodies (e.g., IgE, IgG, IgA, and IgM) against cetuximab
Until all samples are collected.
Sera from head and neck cancer or colorectal cancer patients who were treated with cetuximab will be obtained from Tumor Tissue Repository
Sera from head and neck cancer or colorectal cancer patients who were treated with cetuximab will be obtained from Tumor Tissue Repository
Head and neck cancer or colorectal cancer patients who were treated with cetuximab
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center
538 participants (actual enrollment reported by the registry).
First Submitted
May 9, 2009
First Posted
May 12, 2009
Study Start
November 2006
Date type not reportedThis date has not been verified as actual or estimated.
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)Last Updated
April 2, 2013
Record last verified: 2013-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: